|
FNIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.76340000000286E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.09100000000606E-05 |
| Normal-vs-Stage2 |
8.678300E-02 |
| Normal-vs-Stage3 |
1.264070E-03 |
| Normal-vs-Stage4 |
7.978400E-04 |
| Stage1-vs-Stage2 |
1.294650E-01 |
| Stage1-vs-Stage3 |
5.990800E-01 |
| Stage1-vs-Stage4 |
7.953400E-01 |
| Stage2-vs-Stage3 |
3.166800E-01 |
| Stage2-vs-Stage4 |
1.691380E-01 |
| Stage3-vs-Stage4 |
5.397000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30140000000634E-05 |
| Normal-vs-AfricanAmerican |
1.930230E-01 |
| Normal-vs-Asian |
5.592300E-04 |
| Caucasian-vs-AfricanAmerican |
1.882820E-01 |
| Caucasian-vs-Asian |
4.492200E-01 |
| AfricanAmerican-vs-Asian |
9.019800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.396200E-04 |
| Normal-vs-Female |
8.36040000000704E-05 |
| Male-vs-Female |
8.884600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.228000E-04 |
| Normal-vs-Age(41-60Yrs) |
4.25210000000176E-05 |
| Normal-vs-Age(61-80Yrs) |
4.897600E-03 |
| Normal-vs-Age(81-100Yrs) |
7.970000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.327400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.965200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.222600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.612600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.573400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.641200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.588200E-01 |
| Classical-VS-Follicular |
7.372200E-01 |
| Classical-VS-Other |
1.056030E-01 |
| Classical-VS-Normal |
1.842130E-03 |
| Tall-VS-Follicular |
8.742800E-01 |
| Tall-VS-Other |
1.215960E-01 |
| Tall-VS-Normal |
2.190100E-02 |
| Follicular-VS-Other |
2.286000E-01 |
| Follicular-VS-Normal |
3.884300E-03 |
| Other-VS-Normal |
1.219840E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.89909999999527E-05 |
| Normal-vs-N1 |
6.017600E-04 |
| N0-vs-N1 |
5.592200E-01 |
|
|
